MedTrace Logo

RT-PCR Database Analysis for COVID-19 Infections and Re-infection

NCT04653844 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 7000000

Last updated 2022-01-04

No results posted yet for this study

Summary

The SARS-Cov2 pandemic remains associated with many concerns. One of the them is the real frequency of likely re-infection and subsequently the level of protection conferred by the acquired immunity following primary-infection. We propose to analyze a large set of laboratory data produced since the early beginning of the SARS-Cov2 spread in the French population to identify recurrent infection events and, more generally, gain insight about infection kinetics.

Conditions

Sponsors & Collaborators

  • Laboratoire CERBA-MPL

    collaborator UNKNOWN

  • CNRS (MIVEGEC)

    collaborator UNKNOWN

  • Nîmes University Hospital

    collaborator UNKNOWN

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Vincent Foulongne, PhD · UH MONTPELLIER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2022-12-31
Completion
2023-01-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04653844 on ClinicalTrials.gov